[Sundaycommunity] CBC censors these scientific studies demonstrating effectiveness of NaturaL Immunity to covid

[Arthur Blomme]

Hi all

The question I keep asking myself is how can you believe anything the 
CBC says if they are so biased in their presentation of Covid19 science.

For the past several months the CBC has demonstrated collusion with big 
Pharma by censoring information that does not support the need for 
vaccine mandates.   While natural immunity has been considered the 
consequence of surviving all infectious diseases to this point, in 
Canada this logic is denied and not given due consideration by Big 
Pharma, the CBC and most other mainstream media sources. In Canada, if 
you survive the disease and acquire natural immunity you will still be 
mandated to get both jabs to save your job.

The general belief seems to be that surviving Covid does not give you 
immunity; despite a plethora of scientific studies from reputable 
journals demonstrating the superiority of natural immunity.  As I have 
said repeatedly, the only data presented in the media is data that 
support the thesis that vaccines are our only salvation from this 
horrible disease.  No nuances allowed.   This policy is extremely 
prejudicial to the survivors of Covid19. In addition to having the best 
protection available, those with natural immunity also face higher 
stakes when taking the COVID shot, as their preexisting immunity makes 
them more prone to side effects. Life 2021; 11(3): 249, Discussion 
<https://www.mdpi.com/2075-1729/11/3/249/htm>

Moreover, the dogmatic ‘get vaccinated’ position constitutes a lack of 
honesty about the data .  The policy bias in favor of vaccines ignores 
many other facts as well, such as the relative risks of vaccines, 
especially for the young.

/Below is a list of some of the studies that indicate the comparative 
effectiveness of natural immunity over covid19 vaccines:
/

    An Israeli study^4 that included 700,000 people, posted August 25,
    2021, on the preprint server medRxiv, found those with prior
    SARS-CoV-2 infections were 27 times less likely to develop
    symptomatic infection for a second time, compared to those who were
    vaccinated.

      * ^4 medRxiv August 25, 2021
        <https://www.medrxiv.org/content/10.1101/2021.08.24.21262415v1>

    A June 11, 2021, Public Health England report^5 also showed that as
    a hospital patient, you are six times more likely to die of the
    COVID Delta variant if you are fully vaccinated, than if you are not
    vaccinated at all.

      * ^5 Public Health England Briefing 15 June 3, 2021
        <https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/993879/Variants_of_Concern_VOC_Technical_Briefing_15.pdf>

    October 4, 2021, Project Veritas released a video^6 (below) in which
    Pfizer scientist Nick Karl states, “When somebody is naturally
    immune … they probably have more antibodies against the virus,”
    correctly explaining that “When you actually get the virus, you’re
    going to start producing antibodies against multiple pieces of the
    virus … So, your antibodies are probably better at that point than
    the [COVID] vaccination.”

      * ^6 Project Veritas October 4, 2021
        <https://www.projectveritas.com/news/pfizer-scientist-your-antibodies-are-probably-better-than-the-vaccination/>

    Yet another senior associate scientist at Pfizer, Chris Croce, is
    caught saying that “You’re protected for longer” if you have natural
    COVID antibodies compared to the COVID vaccine. Croce adds that he
    works “for an evil corporation” that is “run on COVID money.

      * ^7 Reddit COVID-19 and Immunity
        <https://www.reddit.com/r/LockdownSkepticism/comments/oy84pe/covid19_and_immunity/>

    ”Science Immunology October 2020  found that “RBD-targeted
    antibodies are excellent markers of previous and recent infection,
    that differential isotype measurements can help distinguish between
    recent and older infections, and that IgG responses persist over the
    rst few months after infection and are highly correlated with
    neutralizing antibodies.”

      * ^8 Science Immunology October 8, 2020; 5(52): eabe0367
        <https://immunology.sciencemag.org/content/5/52/eabe0367>

    The BMJ January 2021^9 concluded that “Of 11, 000 health care
    workers who had proved evidence of infection during the first wave
    of the pandemic in the U.K. between March and April 2020, none had
    symptomatic reinfection in the second wave of the virus between
    October and November 2020.”


      * ^9 BMJ 2021;372:n99 <https://www.bmj.com/content/372/bmj.n99>

    Science February 2021^10 reported that “Substantial immune memory is
    generated after COVID-19, involving all four major types of immune
    memory [antibodies, memory B cells, memory CD8+ T cells, and memory
    CD4+ T cells]. About 95% of subjects retained immune memory at
    ~6 months after infection.

    Circulating antibody titters were not predictive of T cell memory.
    Thus, simple seriological tests for SARS-CoV-2 antibodies do not
    reflect the richness and durability of immune memory to SARS-CoV-2.
    A 2,800-person study found no symptomatic reinfections over a
    ~118-day window, and a 1,246-person study observed no symptomatic
    reinfections over 6 months.”symptomatic reinfections over 6 months.”

      * ^10 Science February 5, 2021; 371(6529): eabf4
        <https://science.sciencemag.org/content/371/6529/eabf4063>

    A February 2021 study posted on the prepublication server medRxiv^11
    concluded that “Natural infection appears to elicit strong
    protection against reinfection with an efficacy ~95% for at least
    seven months.”

      * medrxiv February 8, 2021 DOI: 10.1101/2021.01.15.21249731
        <https://www.medrxiv.org/content/10.1101/2021.01.15.21249731v2>

    An April 2021 study posted on medRxiv^12 reported “the overall
    estimated level of protection from prior SARS-CoV-2 infection for
    documented infection is 94.8%; hospitalization 94.1%; and severe
    illness 96·4%. Our results question the need to vaccinate
    previously-infected individuals.”

      * ^12 medRxiv April 24, 2021 (PDF)
        <https://www.medrxiv.org/content/10.1101/2021.04.20.21255670v1.full.pdf>

    Another April 2021 study posted on the preprint server BioRxiv^13
    concluded that “following a typical case of mild COVID-19,
    SARS-CoV-2-specific CD8+ T cells not only persist but continuously
    differentiate in a coordinated fashion well into convalescence, into
    a state characteristic of long-lived, self-renewing memory.”

      * ^13 BioRxiv April 29, 2021 DOI: 10.1101/2021.04.28.441880
        <https://www.biorxiv.org/content/10.1101/2021.04.28.441880v1>


    A May 2020 report in the journal Immunity^14 confirmed that
    SARS-CoV-2-specific neutralizing antibodies are detected in COVID-19
    convalescent subjects, as well as cellular immune responses. Here,
    they found that neutralizing antibody titers do correlate with the
    number of virus-specific T cells.

      * ^14 Immunity June 16, 2020; 52(6): 971-977.E3
        <https://www.cell.com/immunity/fulltext/S1074-7613(20)30181-3?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1074761320301813%3Fshowall%3Dtrue>


    A May 2021 Nature article^15 found SARS-CoV-2 infection induces
    long-lived bone marrow plasma cells, which are a crucial source of
    protective antibodies. Even after mild infection, anti-SARS-CoV-2
    spike protein antibodies were detectable beyond 11 months’
    post-infection.

      * ^15 Nature 2021; 595: 421-425
        <https://www.nature.com/articles/s41586-021-03647-4>

    A May 2021 study in E Clinical Medicine^16 found “antibody detection
    is possible for almost a year post-natural infection of COVID-19.”
    According to the authors, “Based on current evidence, we hypothesize
    that antibodies to both S and N-proteins after natural infection may
    persist for longer than previously thought, thereby providing
    evidence of sustainability that may influence post-pandemic planning.”

      * ^16 E Clinical Medicine 2021; 36: 100902 (PDF)
        <https://www.thelancet.com/action/showPdf?pii=S2589-5370(21)00182-6>

    Cure-Hub data^17 confirm that while COVID shots can generate higher
    antibody levels than natural infection, this does not mean
    vaccine-induced immunity is more protective. Importantly, natural
    immunity confers much wider protection as your body recognizes all
    five proteins of the virus and not just one. With the COVID shot,
    your body only recognizes one of these proteins, the spike protein.

      * ^17 Cure-hub June 11, 2021
        <https://www.cure-hub.com/post/covid-19-natural-infection-vs-vaccine-immunity>

    A June 2021 Nature article^18 points out that “Wang et al. show
    that, between 6 and 12 months after infection, the concentration of
    neutralizing antibodies remains unchanged. That the acute immune
    reaction extends even beyond six months is suggested by the authors’
    analysis of SARS-CoV-2-specific memory B cells in the blood of the
    convalescent individuals over the course of the year.

    These memory B cells continuously enhance the reactivity of their
    SARS-CoV-2-specific antibodies through a process known as somatic
    hypermutation. The good news is that the evidence thus far predicts
    that infection with SARS-CoV-2 induces long-term immunity in most
    individuals.”

      * ^18 Nature June 14, 2021
        <https://www.nature.com/articles/d41586-021-01557-z>

    Another June Nature paper^19 concluded that “In the absence of
    vaccination antibody reactivity [to the receptor binding domain
    (RBD) of SARS-CoV-2], neutralizing activity and the number of
    RBD-specific memory B cells remain relatively stable from 6 to 12
    months after infection.” According to the authors, the data suggest
    “immunity in convalescent individuals will be very long lasting.”

      * ^19 Nature July 2021; 595(7867): 426-431
        <https://pubmed.ncbi.nlm.nih.gov/34126625/>

    A September 2021 paper^20 in the European Journal of Immunology
    assessed the persistence of serum antibodies following wild-type
    SARS-CoV-2 infection at 8 and 13 months after diagnosis in 367
    patients. At 13 months, neutralizing antibodies against the
    wild-type virus persisted in 89% of cases, and SARS-CoV-2 spike
    immunoglobulin G (S-IgG) persisted in 97% of cases.

      * ^20 European Journal of Immunology September 24, 2021 DOI:
        10.1002/eji.202149535
        <https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202149535>



Peace

Art Blomme


-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.integralshift.ca/private.cgi/sundaycommunity-integralshift.ca/attachments/20211016/03225ac1/attachment-0001.html>